Synapse - American Society of Hematology

Results (5323)

Role of B cell recovery in relapse risk and CD19 phenotype following real-world use of tisagenlecleucel for pediatric B-acute lymphoblastic leukemia: A multi-institutional retrospective study

Meeting Abstract

Zeng, X. L.; Kwon, S.; Vatsayan, A.; Baggott, C.; Prabhu, S.; John, S.; Pacenta, H. L.; Phillips, C. L.; Rossoff, J.; Talano, J. A.; more...
Blood (2024)

Fulltext@MSK | Save

Feasibility and implementation of the ASH Research Collaborative's COVID-19 OutcomeS in Myeloma and the Impact of VaCcines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections

Meeting Abstract

Wood, W. A.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Anderson, K. C.; Kumar, S.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
Blood (2024)

Fulltext@MSK | Save

Treatment of relapsed/refractory multiple myeloma with ciltacabtagene autoleucel or idecabtagene vicleucel in racial minorities - A multicenter study

Meeting Abstract

Chang, D.; Habib, A.; Vegel, A.; Struble, E.; Shaikh, H.; Strouse, C.; Green, K. M.; Mushtaq, M. U.; Mahmoudjafari, Z.; Hashmi, H.; more...
Blood (2024)

Fulltext@MSK | Save

The LMO2-LDB1-TAL1 complex regulates transcription networks in AML relapse

Meeting Abstract

Dunham, N.; Wang, Z.; Neelamraju, Y.; Guo, Y.; Hardwick, J.; Maier, B.; Meydan, C.; Gandara, J. A.; Lee, T.; Prajapati, S.; more...
Blood (2024)

Fulltext@MSK | Save

TET2 and TP53 mutations cooperate in leukemia development and modulate the response to inflammation

Meeting Abstract

Vela, P. S.; Kelly, B.; Brady, C.; Foox, J.; Glass, J.; Levine, R. L.; Shih, A. L.
Blood (2024)

Fulltext@MSK | Save

Interferon inhibits netosis in neutrophils derived from patients with myeloproliferative neoplasms in a neutrophil subpopulation-specific manner

Meeting Abstract

Goldberg, I.; Partouche, S.; Halperin, E.; Atamna, B.; Abulafia, A. S.; Shapira, S.; Samara, A.; Gover-Proaktor, A.; Leader, A.; Spectre, G.; more...
Blood (2024)

Fulltext@MSK | Save

Asciminib provides long-term, durable molecular responses in patients with T3151-mutated CML-CP: Final analysis from a phase 1 trial

Meeting Abstract

Cortes, J. E.; Rea, D.; Mauro, M. J.; Hochhaus, A.; Kim, D. W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M. W.; more...
Blood (2024)

Fulltext@MSK | Save

Genetic diversity drives differing morphological and clinical presentation and survival in myelodysplastic-type CMML with a low absolute monocyte count

Meeting Abstract

Lachowiez, C. A.; Asimomitis, G.; Bernard, E.; Tazi, Y.; Creignou, M.; Germing, U.; Gattermann, N.; Gilkes, A.; Thomas, I.; Bullinger, L.; more...
Blood (2024)

Fulltext@MSK | Save

Representation of older adults in FDA and EMA registrational trials for acute myeloid leukemia (AML)

Meeting Abstract

Pugh, K.; Juthani, R.; Torka, P.; Neuendorff, N.
Blood (2024)

Fulltext@MSK | Save

Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience

Meeting Abstract

Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
Blood (2024)

Fulltext@MSK | Save

American Society of Hematology

People

Groups

Results (5323)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

American Society of Hematology – authorized name for: